ArticleFrontiers in oncology2019

Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma.

Shan-Zhou Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.